Collectively, these findings establish a robust molecular framework for understanding GV and HPV16 co-infection pathogenesis and highlight IFIT1 and RSAD2 as promising diagnostic biomarkers and therapeutic targets in HPV-related diseases. This evidence concerns the gene IFIT1 and coinfection.